Neuroone Medical Technologies (NMTC) Change in Inventory (2020 - 2026)

Neuroone Medical Technologies (NMTC) has reported Change in Inventory for 7 consecutive years, with $191839.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Inventory rose 171.75% year-over-year to $191839.0; the trailing twelve-month figure through Jun 2026 stood at $396053.0 (up 254.35% YoY), and the FY2025 full-year result was -$398348.0, down 143.85% from the prior year.
• Change in Inventory slipped to $191839.0 in Q2 2026 per NMTC's latest filing, from $433268.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $841721.0 in Q3 2024 and bottomed at -$704292.0 in Q4 2024.
• Historically, Change in Inventory has averaged $115118.8 across 5 years, with a median of $204587.5 in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Inventory jumped 3854.2% in 2023, then slumped 496.71% in 2024.
• Over 5 years, Change in Inventory stood at $199016.0 in 2022, then sank by 159.31% to -$118029.0 in 2023, then plunged by 496.71% to -$704292.0 in 2024, then rose by 20.39% to -$560658.0 in 2025, then surged by 134.22% to $191839.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $191839.0, $433268.0, and -$560658.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.